BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Leowattana W, Leowattana T. Chronic hepatitis B: New potential therapeutic drugs target. World J Virol 2022; 11(1): 57-72 [PMID: 35117971 DOI: 10.5501/wjv.v11.i1.57]
URL: https://www.wjgnet.com/2307-8960/full/v11/i1/57.htm
Number Citing Articles
1
Yasunari Matsuzaka, Ryu Yashiro. In Silico Protein Structure Analysis for SARS-CoV-2 Vaccines Using Deep LearningBioMedInformatics 2023; 3(1): 54 doi: 10.3390/biomedinformatics3010004
2
Dimitrios Moianos, Maria Makri, Georgia-Myrto Prifti, Aristeidis Chiotellis, Alexandros Pappas, Molly E. Woodson, Razia Tajwar, John E. Tavis, Grigoris Zoidis. N-Hydroxypiridinedione: A Privileged Heterocycle for Targeting the HBV RNase HMolecules 2024; 29(12): 2942 doi: 10.3390/molecules29122942
3
Alla Turshudzhyan, Micheal Tadros. Cautious optimism in anticipation of hepatitis B curative therapiesWorld Journal of Virology 2022; 11(4): 212-215 doi: 10.5501/wjv.v11.i4.212
4
Yang Shi, Zihan Wang, Jingjing Xu, Wenxia Niu, Yubin Wu, Huiyu Guo, Jinmiao Shi, Zonglin Li, Baorong Fu, Yunda Hong, Zikang Wang, Wenjie Guo, Dabing Chen, Xingling Li, Qian Li, Shaojuan Wang, Jiahua Gao, Aling Sun, Yaosheng Xiao, Jiali Cao, Lijuan Fu, Yangtao Wu, Tianying Zhang, Ningshao Xia, Quan Yuan. TCR-like bispecific antibodies toward eliminating infected hepatocytes in HBV mouse modelsEmerging Microbes & Infections 2024; 13(1) doi: 10.1080/22221751.2024.2387448
5
Xiaohan Hu, Liwei Zhao, Mingrong Ou, Yuxin Chen, Hongxia Wei, Yanyan Xia, Hongpan Xu, Miao Li, Jun Wang. Evaluation of reverse transcription-polymerase chain reaction and simultaneous amplification and testing for quantitative detection of serum hepatitis B virus RNAHeliyon 2023; 9(8): e18557 doi: 10.1016/j.heliyon.2023.e18557
6
Youlu Pan, Heye Xia, Yanwen He, Shenxin Zeng, Zhengrong Shen, Wenhai Huang. The progress of molecules and strategies for the treatment of HBV infectionFrontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1128807
7
Ernest C. Agwamba, Hitler Louis, Innocent Benjamin, Chioma G. Apebende, Tomsmith O. Unimuke, Henry O. Edet, Akaninyene Udoikono, Adanna D. Nwagu, Adedapo S. Adeyinka. (E)-2-((3-Nitrophenyl)Diazenyl)-3-Oxo-3-Phenylpropanal: Experimental, DFT Studies, and Molecular Docking InvestigationsChemistry Africa 2022; 5(6): 2131 doi: 10.1007/s42250-022-00468-4
8
L VANEKOVA, M POLIDAROVA, V CHARVAT, Z VAVRINA, V VEVERKA, G BIRKUS, A BRAZDOVA. Development and Characterization of a Chronic Hepatitis B Murine Model With a Mutation in the START Codon of an HBV PolymerasePhysiological Research 2023; 72(1): 37 doi: 10.33549/physiolres.934979
9
Thu Kim Nguyen, Duyet Van Le. Resistant mutations within the hepatitis B virus reverse transcriptase sequence in treatment failure patients with chronic HBV infection in VietnamJournal of Global Antimicrobial Resistance 2023; 33: 35 doi: 10.1016/j.jgar.2023.02.013
10
Sajad Ahmad Bhat, Syed Kazim Hasan, Zahoor Ahmad Parray, Zaheenul Islam Siddiqui, Shabnam Ansari, Ayesha Anwer, Saniya Khan, Fatima Amir, Mahboubeh Mehmankhah, Asimul Islam, Zarrin Minuchehr, Syed Naqui Kazim. Potential antiviral activities of chrysin against hepatitis B virusGut Pathogens 2023; 15(1) doi: 10.1186/s13099-023-00531-6
11
Naveen Kumar, Narendra S. Choudhary. Managing HBV and HCV Infection Pre- and Post-liver TransplantJournal of Clinical and Experimental Hepatology 2024; 14(2): 101287 doi: 10.1016/j.jceh.2023.09.008
12
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Osamu Yoshida, Julio Aguilar, Guillen Nieto Gerardo, Yoichi Hiasa. Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B InfectionBiomedicines 2023; 11(7): 1944 doi: 10.3390/biomedicines11071944
13
Edward J. Gane, Won Kim, Tien Huey Lim, Pisit Tangkijvanich, Jung-Hwan Yoon, William Sievert, Wattana Sukeepaisarnjaroen, Alexander J. Thompson, Vedran Pavlovic, Bernadette Surujbally, Cynthia Wat, Bob D. Brown, Hardean E. Achneck, Man-Fung Yuen. First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infectionJournal of Hepatology 2023; 79(5): 1139 doi: 10.1016/j.jhep.2023.07.026